BridgeBio Pharma (BBIO) Q4 2025 Earnings

29OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.4
-1.2
-1
-0.79

Details

Expected EPS
-0.894137
Actual EPS
-0.95
Surprise EPS
-0.06
Surprise Percent
+6.25%

Description

BridgeBio Pharma (BBIO) has reported earnings of -0.95 per share for Q4 2025.

0 Comments

Share your thoughts